Ceragenix Pharmaceuticals

News - Ceragenix Pharmaceuticals

Rempex Announces Series B Financing of Up to $67.5 Million

2011-11-09 07:00:00

SAN DIEGO, Nov. 9, 2011 /PRNewswire/ -- Rempex Pharmaceuticals, Inc. today announced that it has completed the initial closing of a Series B financing.

Driven by the Uptake of Several Emerging Agents, the MRSA Drug Market Will Increase From $631 Million in 2009 to $752 Million in 2019

2010-11-10 08:30:00

BURLINGTON, Mass., Nov.

NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer

2009-10-19 06:00:00

EMERYVILLE, Calif., Oct. 19 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting

2009-08-21 13:39:00

EMERYVILLE, Calif., Aug. 21 /PRNewswire-FirstCall/ -- NovaBay(R) Pharmaceuticals, Inc.

Trius Awarded $28 Million Contract to Develop Novel Antibiotics

2008-10-22 00:00:05

SAN DIEGO, Oct.

More News (68 articles) »

News - Ceragenix Pharmaceuticals

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health